Brief: Taro Provides Results For Dec 31 2022
Jan 24 (Reuters) - Taro Pharmaceutical Industries Ltd
TARO.N :
* TARO PROVIDES RESULTS FOR DECEMBER 31, 2022
* TARO PHARMACEUTICAL INDUSTRIES LTD QUARTERLY EARNINGS PER
SHARE
$0.19
* TARO PHARMACEUTICAL INDUSTRIES LTD - QTRLY NET SALES OF
$139.2
MILLION WAS LINE WITH PRIOR YEAR QUARTER
* TARO PHARMACEUTICAL INDUSTRIES LTD - WE CONTINUE TO
EXPERIENCE
PRICE PRESSURES PARTICULARLY IN U.S. GENERIC BUSINESS
Source text for Eikon: ID:nBw6yNBrNa
Further company coverage: TARO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma